Home › NDC Lookup › RxCUI directory › RxCUI 284308

Calcium polycarbophil 625 MG Oral Tablet [Fiber Tab] — RxCUI 284308

RxNorm drug concept · Semantic branded drug
RxCUI 284308 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI284308
Official nameCalcium polycarbophil 625 MG Oral Tablet [Fiber Tab]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asFiber Tab 625 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)13,219 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Calcium polycarbophil 625 MG Oral Tablet [Fiber... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Calcium polycarbophil 625 MG Oral Tablet [Fiber Tab] RxCUI 284308

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Calcium polycarbophil 20063
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fiber Tab 217119
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Calcium polycarbophil Oral Tablet 379289
    • Calcium polycarbophil Oral Product 1156593
    • Calcium polycarbophil Pill 1156594
    • Calcium polycarbophil Oral Tablet [Fiber Tab] 571159
    • Fiber Tab Oral Product 1168304
    • Fiber Tab Pill 1168305
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Calcium polycarbophil 625 MG Oral Tablet SCD · 308934
  • Calcium polycarbophil 625 MG SCDC · 335485
  • Calcium polycarbophil Oral Tablet SCDF · 379289
  • Calcium polycarbophil Oral Product SCDG · 1156593
  • Calcium polycarbophil Pill SCDG · 1156594

Brand-Name Concepts

  • Calcium polycarbophil 625 MG [Fiber Tab] SBDC · 574785
  • Calcium polycarbophil Oral Tablet [Fiber Tab] SBDF · 571159
  • Fiber Tab Oral Product SBDG · 1168304
  • Fiber Tab Pill SBDG · 1168305
  • Fiber Tab BN · 217119

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 284308 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-2500-91 90 TABLET, FILM COATED in 1 BOTTLE (0904-2500-91) FIBER TABS Major Pharmaceuticals 2010-09-01
Observed labelers: Major Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.0596
Range $0.0596–$0.0596 · middle 50% $0.0596–$0.0596 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.